M G Crespo-Leiro

Summary

Country: Spain

Publications

  1. doi request reprint Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)
    Maria G Crespo-Leiro
    Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Hospital Universitario A Coruña, La Coruna, Spain
    Transplantation 94:1172-7. 2012
  2. doi request reprint Steroid withdrawal during 5 years following heart transplantation, and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: results from the RESTCO study
    M G Crespo Leiro
    Complejo Hospitalario, Universitario de A Coruña, A Coruna, Spain
    Transplant Proc 44:2631-4. 2012
  3. doi request reprint Heart transplantation
    Maria G Crespo-Leiro
    Unidad de Insuficiência Cardíaca y Trasplante Cardíaco, Hospital Universitario A Coruña, La Coruna, Spain
    Curr Opin Organ Transplant 15:633-8. 2010
  4. doi request reprint Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study
    Maria G Crespo-Leiro
    Hospital Universitario A Coruña, Instituto Ciencias de la Salud, Universidad de La Coruña, La Coruña, Spain
    Clin Transplant 24:E88-93. 2010
  5. doi request reprint Steroid use in heart transplant patients in Spain in the current era: a multicenter survey
    M Crespo-Leiro
    Servicio de Cardiologia, Hospital A Coruña, A Coruna, Spain
    Transplant Proc 41:2244-6. 2009
  6. doi request reprint Gene expression profiling for monitoring graft rejection in heart transplant recipients
    M G Crespo-Leiro
    Unidad de Insuficiência Cardíaca y Trasplante Cardíaco, Hospital Universitario A Coruña, La Coruna, Spain
    Transplant Proc 41:2240-3. 2009
  7. doi request reprint The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry
    M G Crespo-Leiro
    Servicio de Cardiologia, H A Coruña, Hospital Universitario A Coruña, La Coruna, Spain
    Transplant Proc 42:3011-3. 2010
  8. ncbi request reprint Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function
    I P Garrido
    Heart Transplant Programme, Juan Canalejo University Hospital, A Coruna, Spain
    J Heart Lung Transplant 24:1226-30. 2005
  9. doi request reprint Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation
    N Suarez-Fuentetaja
    Complexo Hospitalario Universitario A Coruña, A Coruna, Spain
    Transplant Proc 44:2645-8. 2012
  10. doi request reprint Lung cancer after heart transplantation: results from a large multicenter registry
    M G Crespo-Leiro
    Hospital Universitario A Coruña, La Coruna
    Am J Transplant 11:1035-40. 2011

Collaborators

Detail Information

Publications30

  1. doi request reprint Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)
    Maria G Crespo-Leiro
    Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Hospital Universitario A Coruña, La Coruna, Spain
    Transplantation 94:1172-7. 2012
    ..There has been no large evaluation of the ISHLT 2004 acute cellular rejection grading scheme for heart graft endomyocardial biopsy specimens (EMBs)...
  2. doi request reprint Steroid withdrawal during 5 years following heart transplantation, and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: results from the RESTCO study
    M G Crespo Leiro
    Complejo Hospitalario, Universitario de A Coruña, A Coruna, Spain
    Transplant Proc 44:2631-4. 2012
    ..Little information is available regarding the controversial issue of steroid withdrawal following heart transplantation (HT), or instead in the incidence of adverse steroid effects at dosages typically employed in Spain...
  3. doi request reprint Heart transplantation
    Maria G Crespo-Leiro
    Unidad de Insuficiência Cardíaca y Trasplante Cardíaco, Hospital Universitario A Coruña, La Coruna, Spain
    Curr Opin Organ Transplant 15:633-8. 2010
    ..This paper briefly and subjectively reviews a number of the modest or tentative, but noteworthy, advances in heart transplantation that have been made during the past 18 months or so...
  4. doi request reprint Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: results from the CAPRI study
    Maria G Crespo-Leiro
    Hospital Universitario A Coruña, Instituto Ciencias de la Salud, Universidad de La Coruña, La Coruña, Spain
    Clin Transplant 24:E88-93. 2010
    ....
  5. doi request reprint Steroid use in heart transplant patients in Spain in the current era: a multicenter survey
    M Crespo-Leiro
    Servicio de Cardiologia, Hospital A Coruña, A Coruna, Spain
    Transplant Proc 41:2244-6. 2009
    ..We designed a questionnaire to ascertain the attitudes and procedures of a number of Spanish heart transplant units (16) regarding the use/withdrawal of steroids as part of the immunosuppressive maintenance therapy...
  6. doi request reprint Gene expression profiling for monitoring graft rejection in heart transplant recipients
    M G Crespo-Leiro
    Unidad de Insuficiência Cardíaca y Trasplante Cardíaco, Hospital Universitario A Coruña, La Coruna, Spain
    Transplant Proc 41:2240-3. 2009
    ..Gene expression profiling may be a promising tool for this purpose...
  7. doi request reprint The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the Spanish Post-Heart Transplant Tumour Registry
    M G Crespo-Leiro
    Servicio de Cardiologia, H A Coruña, Hospital Universitario A Coruña, La Coruna, Spain
    Transplant Proc 42:3011-3. 2010
    ..We sought to determine the prognosis of various groups of noncutaneous nonlymphomatous (NCNL) cancers after heart transplantation (HT)...
  8. ncbi request reprint Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function
    I P Garrido
    Heart Transplant Programme, Juan Canalejo University Hospital, A Coruna, Spain
    J Heart Lung Transplant 24:1226-30. 2005
    ..Renal dysfunction (RD) is a common complication after heart transplantation (HT), but predictors of post-HT RD have not been clearly identified...
  9. doi request reprint Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation
    N Suarez-Fuentetaja
    Complexo Hospitalario Universitario A Coruña, A Coruna, Spain
    Transplant Proc 44:2645-8. 2012
    ..It has been postulated that indirect determination of IDO serum activity may be a marker of renal graft rejection, but its potential usefulness in heart transplantation (HT) is unknown...
  10. doi request reprint Lung cancer after heart transplantation: results from a large multicenter registry
    M G Crespo-Leiro
    Hospital Universitario A Coruña, La Coruna
    Am J Transplant 11:1035-40. 2011
    ..Curative surgery, performed in 21 of the 28 operable cases, increased Kaplan-Meier 2-year survival to 70% versus 16% among inoperable patients...
  11. ncbi request reprint Late steroid withdrawal after heart transplantation and incidence of acute rejection
    M G Crespo-Leiro
    Area del Corazon, Complejo Hospitalario Juan Canalejo, La Coruna, Spain
    Transplant Proc 39:2372-4. 2007
    ..The objective of this study was to assess the safety of late SW after HT with regard to the occurrence of ARE and to analyze risk factors resulting in a poor evolution...
  12. ncbi request reprint Renal dysfunction after orthotopic heart transplantation: incidence, natural history, and risk factors
    I P Garrido
    Heart Transplant Programme, Juan Canalejo University Hospital Complex, A Coruna, Spain
    Transplant Proc 35:2014-6. 2003
    ..The purpose of this study was to determine the incidence and natural history of renal dysfunction following heart transplantation, and to evaluate a number of variables as risk factors for this condition...
  13. ncbi request reprint Late noncardiac surgery in heart transplant patients
    R Marzoa
    Area del Corazon, Complejo Hospitalario Juan Canalejo, La Coruna, Spain
    Transplant Proc 39:2382-4. 2007
    ..Long-term outcomes of NCS and optimal immunosuppressive management in the perioperative period are not well known. The objective of this study was to analyze the incidence, morbidity, and mortality of late NCS after HT...
  14. doi request reprint The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation
    M G Crespo-Leiro
    Heart Transplant Unit, Cardiology Service, Complejo Hospitalario Universitario Juan Canalejo, La Coruna, Spain
    Transplant Proc 40:3060-2. 2008
    ..Statins, although the treatment of choice for dyslipidemia after heart transplantation (HT), are not always well tolerated or effective. In such cases, administration of ezetimibe may be useful...
  15. ncbi request reprint Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients
    N Domenech
    Research Unit, CHU Juan Canalejo, A Coruna, Spain
    Transplant Proc 35:1994-5. 2003
    ..Expression of these molecules was not above normal during rejection episodes, and for neither was there any statistically significant correlation between expression level and the immunosuppressor drug...
  16. ncbi request reprint Microchimerism after heart transplantation: prevalence, predisposing factors, natural history, and prognosis
    M G Crespo-Leiro
    Programa de Trasplante Cardiaco, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 34:161-3. 2002
  17. ncbi request reprint Hypotension, acidosis and vasodilation syndrome after heart transplant: incidence, risk factors, and prognosis
    M J Paniagua
    Heart Transplant Programme, Juan Canalejo University Hospital Complex, A Coruna, Spain
    Transplant Proc 35:1957-8. 2003
    ..HAV syndrome, the combination of hypotension, acidosis and vasodilation (HAV), is a serious postoperative complication after heart transplantation (HT). Its etiology and prognosis are poorly understood...
  18. ncbi request reprint Value of QT dispersion analysis for noninvasive detection of cardiac allograft rejection
    M Regueiro-Abel
    Programa de Trasplante Cardiaco, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 34:168-70. 2002
  19. ncbi request reprint Absence of enteroviral RNA in hearts explanted from patients with dilated cardiomyopathy
    M G Crespo-Leiro
    Heart Transplant Programme, Hospital Juan Canalejo and Instituto de Ciencias de la Salud, Universidad de La Coruña, Spain
    J Heart Lung Transplant 19:134-8. 2000
    ....
  20. doi request reprint Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase
    R Marzoa-Rivas
    Advanced Heart Failure and Heart Transplant Unit, Hospital Universitario A Coruña, A Coruna, Spain
    Transplant Proc 42:2994-6. 2010
    ..It has been suggested that for adequate maintenance of tacrolimus levels, the total daily dosage should be increased when switching from the conventional twice-daily regimen tacrolimus (CT) to once-daily sustained-release tacrolimus (SR-T)...
  21. doi request reprint Reversal of cardiac cirrhosis following orthotopic heart transplantation
    M G Crespo-Leiro
    Heart Failure and Heart Transplantation Unit, Complejo Hospitalario Universitario Juan Canalejo, La Coruna, Spain
    Am J Transplant 8:1336-9. 2008
    ..Here we report a case of cardiac cirrhosis that underwent complete regression following orthotopic HT, and we discuss the implications of this case...
  22. doi request reprint Prevalence of donor-transmitted coronary artery disease and its influence on heart transplant outcomes
    R Estevez-Loureiro
    Heart Transplant and Advanced Heart Failure Unit, Division of Cardiology, Hospital Universitario A Coruña, La Coruna, Spain
    Transplant Proc 42:2987-91. 2010
    ..It is uncertain whether donor-transmitted coronary artery disease (DTCAD) affects heart transplant (HT) recipients...
  23. doi request reprint Adverse effects of mammalian target of rapamycin inhibitors during the postoperative period after cardiac transplantation
    A Bouzas-Mosquera
    Cardiac Transplant Unit, Area del Corazon, Complexo Hospitalario Universitario Juan Canalejo, A Coruna, Spain
    Transplant Proc 40:3027-30. 2008
    ..Safety of treatment with mammalian target of rapamycin inhibitors (mTORi) in the postoperative period after heart transplantation (HT) is controversial...
  24. ncbi request reprint Pulmonary hypertension and right ventricular failure after heart transplantation: usefulness of nitric oxide
    I Mosquera
    Trasplante Cardiaco, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 34:166-7. 2002
  25. ncbi request reprint Calcineurin inhibitors in heart transplantation
    M G Crespo-Leiro
    Area del Corazon, Hospital Juan Canalejo, La Coruna, Spain
    Transplant Proc 37:4018-20. 2005
    ..The choice of CNIs seems to be currently dictated by their adverse effect profiles, by the results obtained for the individual patient, and possibly by institutional preference...
  26. ncbi request reprint Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy
    M G Crespo-Leiro
    Programa de Trasplante Cardiaco, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 34:113-4. 2002
  27. ncbi request reprint Tacrolimus in heart transplantation
    M G Crespo-Leiro
    Heart Transplant Program, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 35:1981-3. 2003
    ..It may be preferable to CsA for patients with arterial hypertension or intractable dyslipidemia. Current and future studies will clarify the efficacy and safety of regimens combining Tac with MMF or rapamycin...
  28. ncbi request reprint Arterial hypertension
    M G Crespo-Leiro
    Programa de Trasplante Cardiaco, Hospital Juan Canalejo, A Coruna, Spain
    Transplant Proc 34:127-9. 2002
  29. doi request reprint Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population
    M Fernández-Caggiano
    Cardiac Biomarkers Group, Research Unit, INIBIC Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
    Mitochondrion 13:263-8. 2013
    ..We found that compared to healthy controls, the prevalence of haplogroup H was significantly higher in IDC patients (40.0% vs 50.7%, p-value=0.040)...
  30. doi request reprint Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation
    M J Paniagua Martin
    Department of Cardiology, Hospital Universitario A Coruña, A Coruna, Spain
    Transplant Proc 42:3014-6. 2010
    ..The incidence of aspergillosis (ASP) after heart transplantation (HTx) is low (<4%-5%), but the mortality is high (>78%)...